MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cafe pharma'. Sat, 03 Sep 2011 02:38:01 +0100 http://www.medworm.com/index.php?rid=1603410&cid=t_121315_150_f&fid=35779&url=http%3A%2F%2Fwww.pharmamanufacturing.com%2Fonpharma%2F%3Fp%3D2271 LabJabPharma.com, a new forum, aims to do for R&D what Cafe Pharma does for sales.  There are other more formal forums, like the AAAS career forum that are currently very active, but this one is focused on pharma and appears to be modelled after Cafe Pharma. Since it’s so new, it’s a “clean slate” right now. [...] (Source: On Pharma) On Pharma blogs http://www.medworm.com/rss/comments.php?id=1603410 Wed, 09 Jul 2008 19:55:48 +0100 1603410 http://www.medworm.com/index.php?rid=1399647&cid=t_121315_150_f&fid=36939&url=http%3A%2F%2Fscientific-misconduct.blogspot.com%2F2008%2F03%2Fzetia-something-brewing-on-cafe-pharma.html Cafe Pharma, the anonymous bulletin board for Pharmaceutical Sales Representatives, is always amusing and insightful. The mud flows freely. From these anonymous comments today on the Schering Plough board [Link, Link], one wonders what innovations are brewing with Zetia and a "49 day plan". Some great science I suspect. Yesterday, 06:33 PM Zetia 49 StrategyWondered what everyone thinks about this Zetia 49 plan??I hate having extra $$ that I have to spend on Drs that I can barely see. I have a hard time spending all my lunch/dinner $$ now. Can't get docs out to dinner anyway - especially the ones they've targeted for me...... This instruction that we are to have a lunch or dinner EVERY DAY - come on!! Like all the Drs offices aren't booked already for the year - or have stopped doing lunche... Scientific Misconduct Blog blogs http://www.medworm.com/rss/comments.php?id=1399647 Tue, 11 Mar 2008 21:31:00 +0100 1399647 http://www.medworm.com/index.php?rid=1225295&cid=t_121315_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F02%2Fsocial-media-to-congress-piss-off.html I love a Congressional investigation as well as the next guy, especially when it involves purported wrong-doing by pharmaceutical company bigwigs.The House Committee on Commerce investigation into "who knew what when" about the ENHANCE clinical trial is a case in point. Did bigwigs at Schering-Plough cash in stock options well ahead of the negative news?As pointed out by whistleblower Peter Rost on BrandweekNRx, at least a few people inside SP knew that ENHANCE was a failure way back in March, 2007 -- about 10 months prior to the public announcement and a month or two before Schering bigwigs -- including president Carrie Cox -- sold stock (see "New evidence indicates Schering-Plough insiders knew the Vytorin trial was "a bust" on March 13, 2007").These people inside SP were "anonymous" pos... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1225295 Tue, 12 Feb 2008 12:10:00 +0100 1225295 http://www.medworm.com/index.php?rid=1190092&cid=t_121315_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F226143293%2F As early as last spring, there was scuttlebutt about the controversial Vytorin data - the bet-the-franchise study that failed to find any statistical advantage over the much cheaper Zocor in reducing arterial plaque. The results were delayed for nearly two years while the primary endpoint was changed. Meanwhile, Vytorin and Zetia (which, along with Zocor comprise the Vytorin combo therapy) were heavily promoted. And concerns that Schering-Plough execs sold lots of stock last year have sparked investigations by Congress and two state attorneys general. This has all led to the ‘Who knew what and when?’ line of skepticism toward Schering-Plough and Merck, its Vytorin joint venture partner. Schering-Plough has repeatedly argued its execs knew nothing of the results until early this... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1190092 Wed, 30 Jan 2008 22:32:07 +0100 1190092 http://www.medworm.com/index.php?rid=1057324&cid=t_121315_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F11%2Ftrue-confessions-redux-another-md-shill.html Yesterday, I wrote about Dr. Carlat's confession of being a shill for Wyeth (see "Dr. Carlat's True Confession: 199,999 More to Go"). As a follow-up, I decided to see what Carlat is saying on his blog and what drugs reps are saying on Cafe Pharma.Carlat recounted some feedback under his post "Return the 30K, You Cheap Thief", which was inspired by a comment made to the WSJ Health Blog. In my critique, I never suggested that Carlat give back the money. He did, after all, take time off to do lunch-and-learns. Many reps in the Wyeth Company board over at Cafe Pharma, however, suggest that these gigs usually involve little or no work at all and may even be counterproductive (see below).Regarding giving the money back, this is Carlat's retort:"I'd be curious to hear opinions about: A. Whether I... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=1057324 Wed, 28 Nov 2007 13:37:00 +0100 1057324 http://www.medworm.com/index.php?rid=961811&cid=t_121315_150_f&fid=35779&url=http%3A%2F%2Fwww.pharmamanufacturing.com%2Fonpharma%2F%3Fp%3D1334 I guess Cafe Pharma is onto something… Researchers at two U.K. universities have disclosed research which suggests that obscenities in the workplace build morale and teamwork. Their work has been published in the Journal of Leadership and Organizational Development. For more, read on. Too bad Monty Python couldn’t have satirized this study. For my part, I say: Bull—-! [...] (Source: On Pharma) On Pharma blogs http://www.medworm.com/rss/comments.php?id=961811 Thu, 18 Oct 2007 17:35:53 +0100 961811 http://www.medworm.com/index.php?rid=638033&cid=t_121315_150_f&fid=34889&url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2007%2F05%2Fdumb-blonde-reps-vs-slovenly-genius.html Ed Silverman over at Pharmalot posted a fun little item about a poll that Cafe Pharma is currently running.Ed asked "Do Good-Looking Reps Do Better?" or rather that was the gist of the poll.The devil is in the details. Here's what the poll asked:Which type of rep gets the best results? An average looking rep that knows their products and can sell? or A super attractive rep that is an idiot and can't sell?Only 16% of respondents chose the super attractive rep option.Unfortunately, this survey can't possibly yield any meaningful insights.To sell (ie, "do better" or "get best results"), you first have to get in the door. So, a better question would have been: Do attractive reps get better access to physicians than do slovenly, but knowledgeable, enthusiastic piglets?I think a lot more than 16... Pharma Marketing Blog blogs http://www.medworm.com/rss/comments.php?id=638033 Fri, 25 May 2007 10:09:00 +0100 638033